These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1976122)

  • 1. Generics in benzodiazepine therapy.
    Mann RJ
    Hosp Pract (Off Ed); 1990 Sep; 25 Suppl 3():24-31; discussion 32-4. PubMed ID: 1976122
    [No Abstract]   [Full Text] [Related]  

  • 2. Can you provide a table of equivalences for benzodiazepines and other marketed benzodiazepine receptor agonists?
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 1997 Aug; 17(4):331. PubMed ID: 9241022
    [No Abstract]   [Full Text] [Related]  

  • 3. Additional generics on the market.
    FDA Drug Bull; 1986 Nov; 16(2):14-5. PubMed ID: 3817341
    [No Abstract]   [Full Text] [Related]  

  • 4. Another round over generics.
    Kosterlitz J
    Natl J (Wash); 1985 Oct; 17(42):2373, 2376. PubMed ID: 10274030
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of 75/75 rule: FDA viewpoint.
    Cabana BE
    J Pharm Sci; 1983 Jan; 72(1):98-100. PubMed ID: 6827472
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory perspectives and the benzodiazepines.
    Tocus EC; Nelson RC; Vocci FJ
    J Psychoactive Drugs; 1983; 15(1-2):151-7. PubMed ID: 6136566
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of generics will mean cost savings.
    Nelson G
    Internist; 1979 May; 20(4):6-8. PubMed ID: 10242132
    [No Abstract]   [Full Text] [Related]  

  • 8. Biokinetics of transdermal therapeutic medicinal form of phenazepam.
    Golovenko NY; Kravchenko IA; Zin'kovskii VG; Andronati SA; Aleksandrova AI; Ovcharenko NV; Larionov VB
    Bull Exp Biol Med; 2000 Dec; 130(12):1153-5. PubMed ID: 11276308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In defense of the Drug Research Board.
    Azarnoff DL
    JAMA; 1975 Aug; 233(5):425-6. PubMed ID: 1173852
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibiotic batch certification and bioequivalence.
    DeSante KA; DiSanto AR; Chodos DJ; Stoll RG
    JAMA; 1975 Jun; 232(13):1349-51. PubMed ID: 1173399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral sedation for the apprehensive dental patient.
    Koerner KR
    Dent Today; 2000 Apr; 19(4):96, 98-101; quiz 101, 151. PubMed ID: 19750734
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Dec; 67(244):77668-75. PubMed ID: 12492102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects for bioavailability and bioequivalence revision: possible implications on clinical pharmacology.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):453-9. PubMed ID: 3683020
    [No Abstract]   [Full Text] [Related]  

  • 14. Doctors are pivotal to prescription struggle.
    Chapman S
    Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
    [No Abstract]   [Full Text] [Related]  

  • 15. Benzodiazepine prescription regulations.
    Sampson WI
    JAMA; 1992 Dec; 268(23):3316-7. PubMed ID: 1360547
    [No Abstract]   [Full Text] [Related]  

  • 16. [The mechanism of action of benzodiazepine and its consequences for therapy].
    Cugurra F
    Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of bioavailability and bioequivalence revision: possible implications on clinical pharmacology.
    Glasser AC
    Methods Find Exp Clin Pharmacol; 1987 Jul; 9(7):449-52. PubMed ID: 3683019
    [No Abstract]   [Full Text] [Related]  

  • 18. Consequences of the 1989 New York State triplicate benzodiazepine prescription regulations.
    Weintraub M; Singh S; Byrne L; Maharaj K; Guttmacher L
    NIDA Res Monogr; 1993; 131():279-93. PubMed ID: 8105386
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pharmacokinetic characteristics of fenazepam in epileptics].
    Maksutova EL; Sariev AK; Zherdev VP; Voronina TA; Zheleznova EV
    Eksp Klin Farmakol; 1994; 57(2):16-8. PubMed ID: 7911365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approach in bioavailability study of two formulations of ethyl loflazepate.
    Ba BB; Iliadis A; Durand A; Berger Y; Cano JP
    Arzneimittelforschung; 1988 Oct; 38(10):1486-9. PubMed ID: 2904268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.